Increased risk of arterial thromboembolic events with combination lenalidomide/dexamethasone therapy for multiple myeloma.
about
Increased risk of arterial thromboembolic events with combination lenalidomide/dexamethasone therapy for multiple myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Increased risk of arterial thr ...... therapy for multiple myeloma.
@en
type
label
Increased risk of arterial thr ...... therapy for multiple myeloma.
@en
prefLabel
Increased risk of arterial thr ...... therapy for multiple myeloma.
@en
P2860
P50
P1476
Increased risk of arterial thr ...... e therapy for multiple myeloma
@en
P2093
Lara Zuberi
P2860
P304
P356
10.1080/14737140.2017.1330153
P577
2017-05-23T00:00:00Z